Dr. Adam Robert Klang, MD

Dr. Klang practices at Kern River Transitional Care in Bakersfield, California.

Dr. Klang's NPI, 1386732246, was assigned on October 10, 2006. Dr. Klang graduated from American University of the Caribbean School of Medicine in 1996. Dr. Klang holds California license A66296.

Dr. Klang's primary practice is Kern River Transitional Care, at 5151 Knudsen Drive, Bakersfield, CA 93308 in Kern County. The practice phone is (661) 325-9900.

Dr. Klang's primary practice is Kern River Transitional Care in Bakersfield, California. Dr. Klang is also affiliated with Kern Medical. The medical group on file is Medical Associates of Bakersfield. Dmand AI also links Dr. Klang to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Klang practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Klang's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Klang is board certified in internal medicine by the American Board of Internal Medicine. Dr. Klang is licensed in California.

Dmand AI lists acid reflux, acute gastroduodenitis, acute skin infection, aneurysm, anxiety, arthritis, asthma and atrial fibrillation and flutter among the conditions Dr. Klang treats.

CMS data shows 10,866 Medicare services from Dr. Klang across 9 procedure codes in 2024, for 705 Medicare patients. Medicare paid $802,385 for them.

CMS counts 705 Medicare patients who saw Dr. Klang in 2024. The largest group is 75 to 84, with 227 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 55% are also on Medicaid. Their average risk score is 2.42, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Klang's median patient age at 71, with 53% women.

In 2024, Dr. Klang wrote 12,634 Medicare Part D claims for 596 patients. 88% of them were for generic drugs. CMS names the drug for 11,996 of them, across 129 drugs with 11 or more claims each, at $273,837 in total drug cost. In 2023, CMS named 10,764 claims across 127 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 12 out of 100 for Dr. Klang for performance year 2024, reported individually.

CMS Open Payments shows 131 general payments to Dr. Klang from 17 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 92% of the total. Pfizer Inc. paid the most, $1,228.

Dr. Klang graduated from American University of the Caribbean School of Medicine in 1996.

Dr. Klang is in network with 6 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 5. Check the plan with the practice before a visit.